UCB SA Total Liabilities

Latest as of June 2026: €8.98 Billion EUR ≈ $10.50 Billion USD

UCB SA total liabilities. Based on the latest financial reports, UCB SA (UCB) has total liabilities worth €8.98 Billion EUR (≈ $10.50 Billion USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See UCB SA (UCB) defensive interval to measure how many days the company can operate on defensive assets alone.

Total Liabilities of UCB SA (2000–2025)

Total liabilities of UCB SA from 2000 to 2025. This chart illustrates how UCB SA's total liabilities have evolved over time, based on quarterly financial data. Check UCB SA asset resilience ratio to evaluate the company's liquid asset resilience ratio.

UCB SA Competitors by Total Liabilities

The table below lists competitors of UCB SA ranked by their total liabilities.

Company Country Total Liabilities
ERSTE GP BNK AG ADR 1/2
F:EBOR
Germany €409.72 Billion
Chunghwa Telecom Co
TW:2412
Taiwan NT$135.08 Billion
RIO Tinto Ltd
AU:RIO
Australia AU$61.12 Billion
3I GROUP PLC ADR 1/2
F:IGQ
Germany €1.45 Billion
FORTESCUE MET.GR.SP.ADR 2
F:FVJA
Germany €11.33 Billion
Roper Technologies Inc
NASDAQ:ROP
USA $16.47 Billion
Powszechna Kasa Oszczednosci Bank Polski SA
WAR:PKO
Poland zł533.98 Billion
Semiconductor Manufacturing Intl Co
SHG:688981
China CN¥17.25 Billion

Liability Composition Analysis (2000–2025)

This chart breaks down UCB SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is UCB SA's balance sheet.

Liquidity & Leverage Metrics

UCB SA Total Liabilities Ratios Explained

UCB SA total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 1.20 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.77 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.44 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how UCB SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for UCB SA (2000–2025)

The table below shows the annual total liabilities of UCB SA from 2000 to 2025.

Year Total Liabilities Change
2025-12-31 €7.29 Billion
≈ $8.52 Billion
-0.37%
2024-12-31 €7.32 Billion
≈ $8.56 Billion
+11.49%
2023-12-31 €6.56 Billion
≈ $7.67 Billion
-3.53%
2022-12-31 €6.80 Billion
≈ $7.95 Billion
+16.83%
2021-12-31 €5.82 Billion
≈ $6.81 Billion
-3.69%
2020-12-31 €6.05 Billion
≈ $7.07 Billion
+48.50%
2019-12-31 €4.07 Billion
≈ $4.76 Billion
-4.39%
2018-12-31 €4.26 Billion
≈ $4.98 Billion
+1.87%
2017-12-31 €4.18 Billion
≈ $4.89 Billion
-11.70%
2016-12-31 €4.74 Billion
≈ $5.54 Billion
-12.48%
2015-12-31 €5.41 Billion
≈ $6.32 Billion
+2.89%
2014-12-31 €5.26 Billion
≈ $6.15 Billion
-3.29%
2013-12-31 €5.44 Billion
≈ $6.36 Billion
+14.05%
2012-12-31 €4.77 Billion
≈ $5.57 Billion
+9.46%
2011-12-31 €4.36 Billion
≈ $5.09 Billion
-0.50%
2010-12-31 €4.38 Billion
≈ $5.12 Billion
-6.93%
2009-12-31 €4.70 Billion
≈ $5.50 Billion
-14.60%
2008-12-31 €5.51 Billion
≈ $6.44 Billion
+4.08%
2007-12-31 €5.29 Billion
≈ $6.19 Billion
-7.50%
2006-12-31 €5.72 Billion
≈ $6.69 Billion
+147.83%
2005-12-31 €2.31 Billion
≈ $2.70 Billion
-32.29%
2004-12-31 €3.41 Billion
≈ $3.98 Billion
+160.76%
2003-12-31 €1.31 Billion
≈ $1.53 Billion
+23.83%
2002-12-31 €1.06 Billion
≈ $1.23 Billion
-10.05%
2001-12-31 €1.17 Billion
≈ $1.37 Billion
+6.95%
2000-12-31 €1.10 Billion
≈ $1.28 Billion
--

About UCB SA

BR:UCB Belgium Biotechnology
Market Cap
$60.25 Billion
€51.54 Billion EUR
Market Cap Rank
#695 Global
#4 in Belgium
Share Price
€270.30
Change (1 day)
-0.88%
52-Week Range
€197.90 - €285.40
All Time High
€285.40
About

UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide. The company offers Cimzia for ankylosing spondylitis (AS), axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, polyarticular juvenile idiopathic arthritis, and rheumatoid arthritis; Vimpat, Keppra, … Read more